Blog
RSS FeedPosted by Michael Wonder on 31 Mar 2021
AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
31 March 2021 - EMA’s safety committee (PRAC) is meeting today in the context of its ongoing review of very ...
Posted by Michael Wonder on 30 Mar 2021
Germany to restrict AstraZeneca use in under-60s over clots
30 March 2021 - German health officials have agreed to restrict the use of AstraZeneca’s coronavirus vaccine in people under 60, ...
Posted by Michael Wonder on 26 Mar 2021
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
26 March 2021 - EMA’s CHMP has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines ...
Posted by Michael Wonder on 26 Mar 2021
Europe slams the brakes on vaccine exports until its needs are met
26 March 2021 - Europe has stepped back from its threat to seize AstraZeneca factories or enact a full vaccine ...
Posted by Michael Wonder on 26 Mar 2021
Attacks on AstraZeneca cast doubt over its vaccine pricing, says top scientist
26 March 2021 - The EU’s attacks on AstraZeneca call into question the company’s decision not to profit from its ...
Posted by Michael Wonder on 25 Mar 2021
Europe’s plans to restrict vaccine exports are dangerous
24 March 2021 - For itself—and for the world. ...
Posted by Michael Wonder on 25 Mar 2021
Statement on COVID-19 vaccine supply at Anagni plant in Italy
24 March 2021 - AstraZeneca would like to clarify a number of inaccurate statements relating to COVID-19 Vaccine AstraZeneca doses ...
Posted by Michael Wonder on 25 Mar 2021
COVID-19 Vaccine AstraZeneca – update on ongoing evaluation of blood clot cases
25 March 2021 - Last week, EMA’s safety committee, PRAC, concluded its preliminary review of cases of blood clots, including very ...
Posted by Michael Wonder on 23 Mar 2021
Increasingly, Europeans do not trust AstraZeneca’s vaccine
22 March 2021 - Hesitancy could put the continent’s exit strategy from the pandemic at risk. ...
Posted by Michael Wonder on 22 Mar 2021
EU has 'absolutely no need' of Russia's Sputnik V vaccine, commissioner says
21 March 2021 - The European Union does not need Russia's Sputnik V vaccine for Covid-19 and can achieve immunity ...
Posted by Michael Wonder on 18 Mar 2021
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
18 March 2021 - EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people ...
Posted by Michael Wonder on 17 Mar 2021
Europe’s vaccine suspension may be driven as much by politics as science
16 March 2021 - Once it became clear Germany was pausing, the pressure mounted on other governments to hold off as ...
Posted by Michael Wonder on 17 Mar 2021
We are in the crisis of the century’: Europe threatens to seize AstraZeneca factories
18 March 2021 - Europe has threatened to seize AstraZeneca factories and strip the pharmaceutical giant of its intellectual property ...
Posted by Michael Wonder on 16 Mar 2021
AstraZeneca vaccine fears may be more deadly than any side effect
16 March 2021 - In Europe, vaccination against COVID-19 is off to a worryingly slow start. Just 11 doses for every ...
Posted by Michael Wonder on 16 Mar 2021
Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues
16 March 2021 - EMA’s safety committee (PRAC) made further progress today in its detailed evaluation of cases of blood clots, ...